Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Change in Account Payables (2016 - 2025)

Nutex Health's Change in Account Payables history spans 15 years, with the latest figure at $35.5 million for Q3 2025.

  • For Q3 2025, Change in Account Payables rose 522.79% year-over-year to $35.5 million; the TTM value through Sep 2025 reached $42.6 million, up 385.38%, while the annual FY2024 figure was -$2.0 million, 56.8% up from the prior year.
  • Change in Account Payables for Q3 2025 was $35.5 million at Nutex Health, up from -$165000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $35.5 million in Q3 2025 and bottomed at -$8.4 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $475000.0 (2024), against an average of $2.4 million.
  • The largest YoY upside for Change in Account Payables was 4829.43% in 2024 against a maximum downside of 886.58% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $201504.0 in 2021, then skyrocketed by 2813.56% to $5.9 million in 2022, then plummeted by 218.27% to -$6.9 million in 2023, then soared by 185.52% to $5.9 million in 2024, then skyrocketed by 497.31% to $35.5 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Change in Account Payables are $35.5 million (Q3 2025), -$165000.0 (Q2 2025), and $1.3 million (Q1 2025).